Status | Study |
Recruiting |
Study Name: Genetic Susceptibility Factors for Candidemia. Condition: Invasive Candidiasis Candidemia Date: 2016-07-20 Interventions: Genetic: Analysis of genetic polymorphisms An analysis of the SNPs (single nucleotide polymorphism) of 2 |
Recruiting |
Study Name: STRIVE: CD101 Compared to Caspofungin Followed by Oral Step Down Treatment in Subjects With Candidemia Condition: Candidemia Mycoses Fungal Inf Date: 2016-03-16 Interventions: Drug: CD101 Intravenous antifu |
Recruiting |
Study Name: Serial Therapeutic and Antifungal Monitoring Protocol Condition: Candidemia Date: 2014-06-12 |
Completed |
Study Name: Candidemia in a Pediatric Center and Importance of Central Venous Catheter Removal Condition: Candidemia Date: 2014-03-10 |
Terminated |
Study Name: A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia Condition: Candidemia Candidiasis Date: 2013-11-06 Interventions: Drug: Micafungin Intravenous (IV) |
Completed |
Study Name: Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study) Condition: Candidemia Date: 2012-12-14 |
Recruiting |
Study Name: A Pilot Study for the Use of Biomarkers and Early Treatment of Invasive Candidiasis in Intensive Care Unit (ICU) Patients Condition: Candidemia Date: 2012-11-20 Interventions: Drug: Anidulafungin Anidulafungin at a dose of 200 mg in the first day and 100 mg daily afterwards |
Completed |
Study Name: Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT) Condition: Candidemia Date: 2012-01-25 |
Completed |
Study Name: Early- and Late-onset Candidemia Condition: Candidemia Date: 2011-07-28 |
Completed |
Study Name: Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation Condition: Non-albicans Candidemia Date: 2011-03-15 |